Eli Lilly和Nvidia正在建造一台GPU驱动的AI型超级计算机,以加速药物发现,于2026年1月发射。 Eli Lilly and Nvidia are building a GPU-powered AI supercomputer to speed up drug discovery, launching in January 2026.

Elilly和Nvidia合作建造了一台超级计算机,由1,000多名Nvidia Blackwell Ultra GPUs提供动力,于2026年1月启动,以加速毒品的发现和开发。 Eli Lilly and Nvidia have partnered to build a supercomputer powered by over 1,000 Nvidia Blackwell Ultra GPUs, launching in January 2026 to accelerate drug discovery and development. 由Lilly经营的人工智能驱动系统将同时进行数以百万计的虚拟实验,大大减少了将新治疗方法投放市场的时间和成本。 The AI-driven system, operated by Lilly, will enable millions of virtual experiments simultaneously, drastically cutting the time and cost of bringing new treatments to market. 它将成为“人工智能工厂”, 支持对毒品发现、制造、医学成像 以及个性化医学的研究。 It will serve as an "artificial intelligence factory," supporting research across drug discovery, manufacturing, medical imaging, and personalized medicine. 该倡议扩大了Lilly的开放接入平台Lilly TuneLab,允许生物技术公司在不分享敏感数据的情况下获取专利的AI模型。 The initiative expands Lilly’s open-access Lilly TuneLab platform, allowing biotech firms to access proprietary AI models without sharing sensitive data. 该项目是Lilly500亿美元的美国研发投资的一部分,预计将创造数千个高工资职位。 The project is part of Lilly’s $50 billion U.S. R&D investment and is expected to create thousands of high-wage jobs.